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tion varies among smooth muscle tissues [5]. Caffeine has been 
Abstract The efllux of 45Ca2+ from preloaded intracellular the accepted means with which to identify Ca2+-induced Ca 2+ 
stores of saponin-permeabilised human uterine artery smooth release (CICR) in many excitable cells, however, both human 
muscle cultured cells was used to study the mechanisms nnderly- vascular and myometrial smooth muscle cells do not respond 
ing Ca 2+ release from the sarcoplasmic reticulum (SR). The pres- 
ent paper demonstrates directly a functional Ca 2+ release mecha- to caffeine with a release of intracellular Ca 2+ [6]. The IP 3 
nism that is dependent on an increase in free Ca 2÷ (100 nM-30 receptor can be activated by IP 3 and Ca 2+, and has been shown 
pM) and is completely inhibited by 20 pM Ruthenium red. The to be inhibited by caffeine in some cells [3]. The IP 3 receptor 
amount of Ca 2+ released at 30 pM free Ca 2÷ was reduced by is capable of considerable variability in the sensitivity of IP 3- 
approximately 50% compared to the release at 10 ~M. This induced Ca 2+ release, which may give rise to the phenomenon 
Ca2+-induced Ca 2+ release (CICR) mechanism was not sensitive of quantal Ca 2+ release [7]. These variations may depend on 
to caffeine. Exposure of cells to low free Ca2+-containing solu- receptor types differently expressed from different gene prod- 
tions (10 nM) indicated that a component of the CICR mecha- ucts, alternative splicing or from co-expression of different IP 3 
nism may be functional at basal free Ca 2+ levels of 100 nM. receptor subtypes in a single cell [8,9]. The inhibitory action of 
Application of ryanodine (0.1-100 /tM) induced 45Ca2+ efflux 
caffeine has also been explained by the reduction of IP 3 produc- 
from the sarcoplasmic retlculum and this release was also inhib- 
ited by 20 ~M Ruthenium red. tion in a dose-dependent manner [10]. Parker and Ivorra using 
Xenopus oocytes found that caffeine inhibited responses to IP3 
Key words." CICR; Ryanodine; Saponin; Smooth muscle; and this may be explained by an antagonistic effect of binding 
Human vascular of IP 3 to its receptor [11]. 
The RyR has been studied predominantly in cardiac and 
skeletal muscle and is sensitive to Ca 2+, Mg 2+ and ATP and may 
be modulated by calmodulin and activated by caffeine [12]. The 
1. Introduction physiological role of the RyR in smooth muscle is uncertain, 
however CICR, which is presumed to be the mechanism of 
The processes underlying smooth muscle contraction can RyR-induced Ca 2+ release in cardiac tissue [13], has been sug- 
involve the activation of voltage and receptor operated Ca 2+ gested to occur in skinned smooth muscle [14]. Microspec- 
influx pathways and the mobilisation of Ca 2÷ from an intracel- trofluorimetry studies using intact myometrial smooth muscle 
lular Ca 2÷ store, the sarcoplasmic reticulum (SR). In human cells indicate that a ryanodine-sensitive but caffeine-insensitive 
uterine artery vascular smooth muscle cells agonists uch as Ca 2+ release mechanism ay be operational [15]. Therefore, to 
histamine can activate repetitive oscillations in intracellular investigate directly the activation of these complex responses 
Ca 2+ in the absence of external Ca 2÷ [1]. These histamine-in- in human uterine artery vascular smooth muscle cells, chemi- 
duced oscillations almost certainly involve the production of cally skinned cultured cells have been used to explore the oper- 
inositol 1,4,5-trisphosphate (IP3) and the mobilisation of Ca 2+ ation of a ryanodine-sensitive Ca2+-dependent Ca2+ release 
from an IP3-sensitive intracellular store [2]. mechanism. 
There appear to be two distinct functional intracellular 
mechanisms that are involved in Ca 2+ release, the IP3-sensitive 2. Experimental 
and the ryanodine-sensitive (RyR) receptor channel complexes. 
Physiological studies uggest that different cell types may func- 2.1. Tissue preparation and culture techniques 
Sections of uterine artery (1 cm × 1-2 mm) from the lower uterine tionally express one or both of these receptors [3]. The norep- 
segment were taken, with informed consent, from patients undergoing 
inephrine-induced Ca 2+ release via IP 3 in rat aorta vascular hysterectomy (women under 40 years of age). Ethical approval was 
smooth muscle is unaffected by prior depletion of the caffeine- obtained from Newcastle Area Health Authority. Myocytes were pre- 
2+ sensitive Ca -releasable Ca 2+ pool and vice versa [4]. This pared using a dispase/collagenase dig stion [16] and maintained in 
suggests the presence of at least two functionally separate re- M199 (Gibco Ltd.) supplemented with 10% foetal calf serum, 1% glu- 
leasable pools [4]. There is also evidence that IP3 mobilises all tamine and 2% penicillin/streptomycin at 37°C. Cells were grown to 
confluence in75 cm 2 culture flasks before being passaged onto 12 well 
of the Ca2+-releasable Ca 2+ pools in guinea pig intestinal plastic multiwells for 45Ca 2÷ efflux studies. Cells were not used beyond 
smooth muscle cells, indicating that functional compartmenta- passage number 6. 
2.2. 45 Ca2+ efflux from saponin-permeabilised cultured cells 
*Corresponding author. Fax: (44) (191) 222 6706. Confluent cells, grown in 12-well multiwells, were washed three times 
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with a balanced salt solution containing (mM): 135 NaCI, 5.9 KC1, 1.5 -- 10nM 
CaC12, 1.2 MgCI2, 11.6 HEPES and 11.5 glucose, pH 7.3 to remove the 
culture medium before being fixed to a mechanical shaker. Cells were + 100nM 
permeabilised with 15/ag/ml saponin for 15 min in the following skin- (A) 0.6- 
ning solution (mM): 120 KCI, 10 HEPES, 2 MgCI,, 1 ATP and -- 300nM 
1 EGTA, pH 7.0 at 22°C. The efficiency of skinning was routinely ~ 0.5- ~ lp.M 
checked using trypan blue exclusion staining. Traces of saponin were r.) 
removed by washing the cells three times with loading buffer containing 
0.4- + 10gM (mM): 120 KC1, 10 HEPES, 5 MgCI2, 5 ATP, 0.44 EGTA and 5 NaN~ 
pH 6.89. The mitochondrial Ca -'+ ATPase inhibitor NaN 3 was used to 
eliminate mitochondrial loading and remove any contribution of Ca 2+ ~ 0.3 - 
released from mitochondrial pools to the overall efflux of 45Ca 2+. Non- 
mitochondrial intracellular stores were passively loaded to steady state o = 0.2 - 
with 10/aCi of 45Ca2+ per well for 10 min in 0.5 ml of loading buffer. "~ 
Loading was terminated by washing three times with ice cold loading 
buffer prior to the start of efftux. The efflux buffer contained (mM): ~, 0.1 
120 KCI, 10 HEPES, 1 ATP, 3 EGTA and 5 NAN3. The amount of 
CaCI 2 and MgCI2 required to give solutions of known free Ca 2+ concen- 0 , , j j 
tration was calculated using the program REACT [17] and basal Ca 2+ 4 8 1'2 1'6 20 24 2~8 
was taken to be 100 nM. Ca2+-activated 45Ca2+ release was induced by 
additions of 10 nM-30/aM free Ca 2+ after a steady baseline flux was Time (minutes) 
obtained in 100 nM free Ca 2+. 45Ca2+ was monitored at 4 min time 
intervals and allowed to proceed for 16-20 min. The remaining 45Ca2+ 
in the cells at the end of efltux was determined by solubilising the cells (B) .-~ 0.2 
with 2% SDS. All experiments were carried out at 25°C as skinned cell 
preparations tend to deteriorate more rapidly at higher temperatures 
[18] and the efflux of radiolabelled Ca 2÷ was determined by liquid N 0.15- / ~  
scintillation counting. The loss of 45Ca 2+ at each four minute time point 
was calculated from the cpm as a fraction of the total 45Ca2+ remaining 
(including the final SDS fraction) within the cells at that time point. 
Data are expressed as means + S.E.M. Where appropriate, data were -~, 0.1 - 
statistically analysed using a paired t-test and P values <0.05 were ,~ T 
considered significant. ~ _ ~  
Collagenase, ryanodine and caffeine were obtained from Sigma, UK. .=- - ± 
Medium 199 and other tissue culture materials were from Gibco Ltd., ~o~ 0.05- 
UK. Dispase was from Boehringer Mannheim. 45Ca2÷ was purchased 
from ICN Flow Laboratories. 
0~ 
3. Results ~ 0.01 0'.1 1 1'0 100 
[Ca 2+] gM 
3.1. Ca2+-activated 45Ca2+-release in permeabilised cultured cells 
The rate of 45Ca2+ efflux from saponin-permeabil ised cul- Fig. 1. Ca2+-dependent 45Ca2+ release in saponin-permeabilisedcultured 
human vascular smooth muscle ceils. (A) A typical experiment inwhich 
tured vascular smooth muscle cells was determined by incubat- the free Ca 2+ concentration at 8 min (indicated by arrow) is changed 
ing the cells in a Ca 2÷ solution containing 100 nM free Ca 2+, from 100 nM (D) to 10 nM (m), 300 nM (e), 1/aM (0) and 10/aM (0). 
which was used as it is considered to be close to the free Ca 2÷ The cells were exposed to the indicated free Ca z+ concentrations until 
concentrat ion measured in resting intact cells. When the efflux the end of the experiment. (B) Analysis obtained from experiments in
A plotted as mean change in fractional loss of 45Ca2+ (r/= 6) and the 
reached steady state the bathing Ca 2+ was altered from 100 nM inhibitory effect of 30/aM free Ca 2÷ (n = 3). The data in B represents 
to 10 nM, 300 nM, 1 ¢tM and 10¢tM and the subsequent 45Ca 2+ means + S.E.M. 
release monitored. If a C ICR mechanism is present and opera- 
tional an elevation in the Ca 2÷ concentrat ion of the bathing 
medium should increase the loss of45Ca 2÷ from the SR. Fig. 1A 3.2. Ruthenium red inhibition of Ca2+-induced 45Ca 2÷ release 
shows a typical response obtained using this rational by chang- Ruthenium red has been used to specifically bind and inhibit 
ing the free Ca -,+ level. The response appears to be transient Ca2+-activated Ca 2+ release channel complexes from cardiac 
with 45Ca2+ levels at 10¢tM free Ca 2+ returning to baseline levels muscle SR [19]. To demonstrate directly that the 45Ca2+-de- 
after approximately 8 min. A decrease in free Ca 2+ from a pendent Ca 2÷ release response observed in human vascular 
resting level of 100 nM to 10 nM resulted in a decrease in the smooth muscle cells was operating through a C ICR channel, 
fractional oss of 45Ca2÷, which may demonstrate that Ca 2+- cells were pre-incubated with ruthenium red before the step 
dependent  45Ca2- release may be operating at the basal level of change in bathing free Ca 2+ concentration. Fig. 2A demon- 
100 nM free Ca 2÷. Fig. 1B shows the analysis of the data strates a typical experiment in which pretreatment with 20/ IM 
obtained from 6 separate vascular isolations each with dupli- Ruthenium red completely inhibited the C ICR response initi- 
care samples as indicated in Fig. 1A. The mean change in ated by 10 ¢tM free Ca 2+. The analysis of the mean data indi- 
fractional oss increases from 10 nM to 10/.tM as the bathing cates that Ruthenium red is capable of complete inhibit ion of 
free Ca 2÷ is increased. However, at 30/~M free Ca 2÷ the efftux the CICR response observed at all free Ca 2+ concentrations 
ofa5Ca 2÷ was significantly decreased compared to 10¢tM Ca 2+. used (Fig. 2B). The application of Ruthenium red was also 
This reduction may indicate an inhibitory action of Ca 2÷ on the found to significantly reduce the basal efflux at 100 nM free 
C ICR channel or an effect of an altered driving force for Ca 2+ Ca 2+ to levels similar to those observed at 10 nM free Ca 2+ (Fig. 
etttux from the SR. 2C). This further supports the suggestion that the Ca2+-depend - 
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There was no observable inhibition of release at high ryanodine 
(A) 0.4- - Control concentrations. The dose-dependent release was not affected by 
~'~ 0.35 - • 20p.M Ruthenium Red 20 mM caffeine which also had no effect on the basal efflux of 
~ 45Ca2+ at 100 nM free Ca 2÷ or the Ca2÷-dependent 45Ca2+ release 
0.3- in response to 10/.tM free Ca 2+ (Fig. 3B,C). The ryanodine- 
o Induced Ca 2÷ release was also sensitive to pretreatment with 20 
- 0.25- 
pM Ruthenium red. The presence of Ruthenium red completely 
~ 0.2- blocked the dose-dependent release of 45Ca2* induced by ryan- 
~, odine (Fig. 3D). 
0.15 , , , 
0 4 8 12 1~6 2~1 2'4 2'8 32 
4.  D iscuss ion  
Time (minutes)  
+ - Control 
Both IP 3 receptors and RyR have been isolated from smooth 
(B) ~ 0.175- ~- 20gM Ruthenium Red muscle and shown to be localised to the SR, where they are able 
T to function as Ca 2+ channels enabling the release of Ca 2+ from 
0.15- / ~  the SR [21,22]. The RyR has been shown to be activated 
0.125- through a process of Ca2+-induced Ca 2÷ release (CICR) [14], 
which occurs following an influx of Ca 2+ via the action potential 
= 0.1- and through cyclical SR Ca 2+ release. This release may induce 
0.075 / ~ "- -- v a positive feedback mechanism by which a localised increase of 
~ ± cytoplasmic Ca 2+ can propagate as an intracellular Ca 2÷ wave 
= o05 throughout the cell. Caffeine has been used to demonstrate the 
0.01 0'.1 i 1'o presence of a RyR channel in many cells [3]. The function of 
[Ca 2 ~1 IZM the RyR and the identity of the physiological messenger in- 
(C) .~- volved in activation of the receptor in smooth muscle is un- 
~. 0.3- ÷ known. The use of caffeine to demonstrate a RyR channel 
.~ "r RR 
ili0 
0.2- 
- -  (A/ ~ (B) 
"~ 0.1 - 0.55- 
• = 0.1 - ~ + 
~ 0.08' ~ 0.5. 
• ~ 0.06- "6 0.45" 
100 100 10 10 ~ ~ 0.4" 
[Ca 2+] nM ~ 
._q 0.04- / -~ 0.35- Caffeine 
Fig. 2. Effect of Ruthenium red on the Ca2+-dependent 45Ca 2+ release ~ 0.02- ~. 0.3- mr-~'tr"=',- J 
and basal efflux at 100 nM free Ca 2+. (A) A typical experiment inwhich ~ 0 ~ 0.25 ~ . . . . . . . .  
the CaZ+-dependent 45Ca2+ release in response to 10 pM free Ca 2+ ~ 1 I'o 100 4 8 12 16 2024 28 32 
(arrow) is completely inhibited by prior application of 20 aM Ruthe- 0.1 
nium red (asterisk) until end of the experiment. (B) Analysis of the mean [Ryanodine] I.tM Time (minutes) 
2+ 45 2+ change in fractional loss of 45Ca2+ from control Ca -dependent Ca 
release and Ruthenium red treated permeabilised cells. (C) Bar graph 
of mean responses over a 20 minute period to illustrate the effect of 20 (C) (D) 
/.tM Ruthenium red (RR) on 100 nM and 10 nM free Ca 2÷ basal fluxes + + 
(* denotes tatistical significant difference where P < 0.01). Data repre- ~. 0.4- r5 0.3- 
sents means + S.E.M. for at least four independent experiments, each ,~ ,- ~- ] ~  
with duplicate samples. ~ 0.3.] ~ '~ 
0.2- 
'= 
ent Ca 2+ release mechanism in human vascular smooth muscle ~ o 0.1. 
cells may be active at basal levels of cytoplasmic Ca 2+. ~ 0.1. 
0- -  ~ 0- 
3.3. Effect of ryanodine and caffeine on 45Ca2+ release Control Caffeine RR/Ry Ry 
Ryanodine is known to have specific effects on the C ICR Fig. 3. Effect ofryanodine (0.1-100pM)and 20mM caffeine on 45Ca2+ 
channel of both skeletal and cardiac myocytes and is used to release at 100 nM and 10 pM free Ca 2÷. (A) Mean data of change in 
specifically bind and quantitate the RyR in both skeletal and fractional loss of 45Ca2+ in response to a 4 rain exposure to ryanodine 
at 0.1 pM, 1 ktM, 10pM and 100pM (n = 6). (B) A typical experiment 
cardiac muscle [20]. At low concentrations (< 10 aM)  one of its to demonstrate he lack of caffeine (20 mM) sensitivity on basal efflux 
main actions is to induce Ca 2+ release from SR vesicles incorpo- of permeabilised cells bathed in 100 nM free Ca 2+ (n = 5). (C) Bar graph 
rated with the RyR protein by locking the channel into a per- to demonstrate the lack of effect of a 12 min exposure of 20 mM caffeine 
2+ 45 2+ manently open subconductance state while higher concentra- on the Ca -dependent Ca release in response to 10 ,uM free Ca 2+ 
tions close the channel [20]. Application of ryanodine (0.1-100 (n = 4). (D) Bar graph to demonstrate he inhibition of the ryanodine- 
induced (100 ¢tM) 45Ca2* release by incubation with 20 pM Ruthenium 
pM) to permeabilised cells exposed to 100 nM free Ca 2+ in- red throughout the experiment (n = 4). Data represents 
45 2+ duced a progressive dose-dependent release of Ca (Fig. 3A). means + S.E.M. 
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requires care as the RyR3 isoform expressed in mink lung than one Ca2+-binding site where high Ca 2+ levels may switch 
epithelial cells has been reported to be caffeine-insensitive [23]. the receptor from a high affinity state that can gate Ca 2+ to an 
Permeabilisation f smooth muscle cells with saponin has inactive low affinity state that inhibits release. However, a de- 
allowed filling of the SR with 45Ca2+ and precise control of the crease in the efflux of 45Ca 2+ at high free Ca 2+ concentrations 
cytoplasmic environment. The use of a cell culture monolayer (> 10/aM), may also reflect a decrease in the Ca 2+ driving force 
is ideal as saponin skinning is able to penetrate evenly into the as the free Ca 2+ concentration approaches the luminal Ca 2+ 
extracellular space [18]. Skinned cultured smooth muscle cells concentration. The contribution ofthe decrease in driving force 
are suited for measuring 45Ca -,+ fluxes as it minimises 45Ca2+ to the Ca 2+ efflux rate requires further investigation. 
exchange into the cytoplasm and extracellular space [18]. The RyR Ca R+ channel inhibitor Ruthenium red is a polyca- 
Chemical skinning with saponin to study Ca 2÷ uptake and re- tionic dye that has been reported to inhibit CICR from the SR 
lease by the SR of smooth muscle cells has the advantage of [34]. This inhibitory action of Ruthenium red was used to inves- 
leaving the SR functionally intact [24]. It is therefore possible tigate the sensitivity and nature of the CICR response in human 
to directly stimulate and study a Ca2+-sensitive Ca 2+ release vascular smooth muscle cells. Application of Ruthenium red 
mechanism by accurately altering the Ca 2÷ content of the bath- (20/aM) to the permeabilised cell preparation prevents CICR- 
ing solution. The use of permeabilised cells in this study has mediated responses at all free Ca 2+ concentrations u ed. The 
clearly demonstrated the involvement of free Ca 2+ levels in the basal efflux of 45Ca2+ at 100 nM is also sensitive to Ruthenium 
initiation of a CICR response which is sensitive to Ruthenium red which reduces the basal evels similar to those obtained by 
red in cultured human vascular smooth muscle cells, efflux with 10 nM free Ca 2+. This suggests that the minimal 
It has been shown that Ca -,+ stores in cultured vascular 4SCa-,+ efflux is determined using either of these conditions and 
smooth muscle cells from rat aorta exist as functionally sepa- so further suggests that a component of CICR is operating at 
rate entities [25]. In this two-pool model one is sensitive to IP3 100 nM or basal cytoplasmic Ca 2+ levels. 
and contains IP 3 receptors and the other is sensitive to caffeine The results also indicate that at 100 nM free Ca -,+ there is no 
and Ca 2+ and is associated with a specific RyR [25,26]. These release of Ca 2+ following 20 mM caffeine treatment. Similarly, 
vascular smooth muscle intracellular stores may have both there was no significant enhancement of the CICR response 
RyR and IP3 receptors distributed evenly on elements of the induced in the presence of 20 mM caffeine. This may indicate 
SR. Although there is some physiological evidence to support that the RyR isoform present in these cells is similar to the 
a co-localisation i  neurosecretory PC12 cells [27] most studies isoform identified in the mink lung epithelium [23] which is also 
indicate that these two receptors operate separate Ca 2+ stores, reported to be caffeine-insensitive. We have previously re- 
Studies in the rat vascular smooth muscle cell line A7r5 indicate ported that a ryanodine-sensitive, caffeine-insensitive Ca -,+ re- 
that the two receptors may operate functionally and spatially lease mechanism is present in intact human myometrial smooth 
distinct Ca 2÷ stores [28]. However, the use of this cell line may muscle cells [15]. Molecular cloning of RyR-specific transcripts 
require care in the interpretation f results obtained. Missiaen from human myometrial tissue appear to provide evidence for 
et al. demonstrated a lack of ryanodine and caffeine ffect on the expression of two isoforms, RyR1 and RyR3 [35]. The 
45Ca2+ fluxes induced by AVP and concluded that CICR was myometrial-specific RyR1 isoform may be a tissue-specific 
not present [29]. It is possible that these two stores may interact transcript derived from the RyRI gene that lacks the 'foot' 
in a co-ordinated manner with each other to generate complex region, which is thought o confer caffeine-sensitivity on this 
physiological Ca 2+ signals [3]. receptor [36]. It is possible that human uterine artery smooth 
The results how that varying the free Ca -,+ concentration f muscle in vivo or in the cultured model may possess one or both 
permeabilised cells from 100 nM to 10/aM increased the 45Ca2+ of these isoforms and so confer the shared property of caffeine 
efflux in a dose-dependent manner. The Ca 2+ concentrations insensitivity. This lack of caffeine sensitivity has also been 
used in the efflux studies to induce CICR are within the range demonstrated using chemically skinned myometrial smooth 
used in other saponin-skinned preparations, uch as papillary muscle strips which produced no contractile activity at 0.1-50 
muscle (1-10/aM) [30], smooth muscle of guinea pig taenia mM caffeine [37]. 
caecum (> 3/aM) [31] and rabbit arterial smooth muscle (3-10 Ryanodine has been shown to stimulate or inhibit Ca 2+ fluxes 
/aM) [32]. The observation that reducing the free Ca 2+ concen- in skeletal and cardiac SR depending on the concentration [20]. 
tration to 10 nM reduced the efflux of 45Ca 2+ below baseline At concentrations i  the range of 0.01 10/aM ryanodine, Ca -,+ 
levels is a new observation i these vascular smooth muscle cells release was stimulated, whereas, at higher concentrations i  the 
and any other cell type investigated. This reduction in the basal range 10-300/aM ryanodine, release was inhibited [20]. This 
efflux may be evidence that a component of the CICR response observation suggested that activation and inhibition of SR Ca 2+ 
is operating at basal evels of cytoplasmic Ca 2+. release by ryanodine is mediated by functionally independent 
The CICR channel in other smooth muscle cells has been sites [38]. In human vascular smooth muscle cells application 
suggested to be inoperative at cytoplasmic (100 nM) levels of of 1 100/aM ryanodine induced a progressive dose dependent 
Ca 2+, in fact, the activation of ryanodine-sensitive CICR in the release of Ca -,+ from the SR of saponin-permeabilised c lls 
absence of caffeine required much higher intracellular free Ca 2+ exposed to 100 nM free Ca 2+. The maximal release of 45Ca 2+ by 
levels (> 1/aM) [14,33]. Increasing the free Ca R+ concentration ryanodine is less than the maximal release of 45Ca2+ by 10/aM 
to 30/aM reduced the CICR response to approximately 50% free Ca 2+ in these cells. This observation may reflect he confor- 
of maximal stimulation with 10/aM free Ca -,+ in human arterial mational state of the receptor since ryanodine preferentially 
vascular smooth muscle ceils. This biphasic dependence of the binds to the open state of the channel. In the presence of 
efflux rate with respect to Ca 2+ is similar to the CICR response micromolar Ca 2+ the efflux of 45Ca2+ is maximal and this may 
described in skeletal and cardiac muscle SR [20]. The biphasic indicate that the binding and interaction of ryanodine is de- 
relationship of Ca 2+ release may reflect the operation of more pendent on the free Ca -,+ concentration. The ryanodine-induced 
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45Ca 2+ release was sensitive to 20/,tM Ruthenium red which [13] Fabiato, A. (1983) Am. J. Physiol. 245, C1-C14. 
inhibited the release of Ca 2+ at all concentrations of ryanodine [14] Iino, M. (1989) J. Gen. Physiol. 94, 363 383. 
used. [15] Lynn, S., Morgan, J.M., Gillespie, J.I. and Greenwell, J.R. (1993) 
FEBS Lett. 330, 227 230. 
It has been shown that millimolar Mg 2+ can effectively inhibit [16] Morgan, J.M., Lynn, S., Gillespie, J.I. and Greenwell, J.R. (1993) 
ryanodine binding to skeletal receptors but has little effect on Biochim. Biophys. Acta 1158, 98-102. 
the binding to cardiac receptors [39]. This Mg 2÷ inhibition of [17] Smith, G.L. and Miller, D.J. (1984) Biochim. Biophys. Acta 893, 
ryanodine binding is due to a direct competition between Ca z+ 287 299. 
and Mg 2+ for the Ca 2+ activation site. In the experimental [18] Yamamoto, H. and van Breemen, C. (1986) J. Gen. Physiol. 87, 
369-389. 
protocol used to demonstrate he 45Ca2+ efftux properties, the [19] Rousseau, E., Smith, J.S., Henderson, J.S. and Meissner, G. (1986) 
efflux solutions used contain 2 mM Mg 2+ which apparently did Biophys. J. 50, 1009-1014. 
not effect the responses demonstrated in this paper. Therefore, [20] Coronado, R., Morrissette, J. Sukhareva, M. and Vaughan, D.M. 
the complex responses observed in human vascular smooth (1994) Am. J. Physiol. 266, C1485 C1504. 
muscle cells may be isoform-specific and until a detailed molec- [21] Fleischer, S. and Inui, M. (1989) Annu. Rev. Biophys. Biophys. 
Chem. 18, 333-364. 
ular investigation of the RyR isoforms present is complete the [22] Xu, L., Lai, F.A., Cohn, A., Etter, E., Guerrero, A., Fay, F.S. and 
exact nature of the caffeine-insensitive ryanodine-sensitivity Meissner, G. (1994) Proc. Natl. Acad. Sci. USA 91, 3294-3298. 
and Ca2+-dependent Ca 2÷ release mechanism remains unclear. [23] Giannini, G., Clementi, E., Ceci, R., Marziali, G. and Sorrentino, 
V. (1992) Science 257, 91-94. 
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